Jaro Institute (JARO)

FairStock Score: 51/100 — MIXED

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 39.89% with debt/equity of 0.13 shows high capital efficiency and a conservative balance sheet.
• Sales growth of 38.62% and PEG of 0.12 suggest the market is not fully paying for growth.
• Piotroski F-Score of 7/9 indicates solid profitability, leverage, and operating efficiency fundamentals.
• Promoter holding of 57.33% keeps management aligned with minority shareholders.

Concerns

• Profit growth of 280.72% is likely unsustainable and may reflect a low base; latest quarter net profit is only ₹7 Cr on ₹60 Cr sales.
• Stock at ₹425.05 is near 52-week low of ₹383.50 and far below ₹890, signaling market skepticism.
• ROE is marked N/A, so true return on equity for shareholders is unclear despite healthy ROCE.
• Dividend yield of 0.45% offers little compensation while waiting for growth.

AI Analysis

When I study Jaro Institute, I first look at the numbers the way a shopkeeper inspects inventory. Price is ₹425.05, market cap ₹983 crore, P/E 19.75, and book value is ₹177.89, so I'm paying 2.39 times book. That is not a Graham-style bargain, but for a business growing sales 38.62%, with a PEG of 0.12, the growth appears cheap. The balance sheet is genuinely strong: debt/equity just 0.13 and ROCE of 39.89%, an excellent return on capital. The Piotroski F-Score of 7/9 adds confidence that the reported health is not an illusion. But I must be on guard. Profit growth of 280.72% is too good to be normal; such spikes often come from a low base or a one-time tailwind. The latest quarter tells a quieter story: sales ₹60 crore and net profit ₹7 crore, a decent margin but not remarkable. The stock trades around ₹425, near its 52-week low of ₹383.50 and far below the ₹890 high. Mr. Market is clearly worried. I don't treat a falling stock as automatic opportunity—I need to know whether the business's moat is widening or eroding. E-learning is crowded and competitive; I see no evidence of pricing power or customer lock-in here. Promoter holding of 57.33% is reassuring. But a dividend yield of 0.45% means shareholders are not paid to be patient. With FairStock Score of 55/100, this is a steady company, not a spectacular one. I would want continued high ROCE, stable quarterly margins, and proof that growth can compound before I part with capital. In investing, the price is what you pay; the question is whether Jaro's earnings durability gives me a value in return. So far, I am interested, not convinced.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer